logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
E

Eva Domingo‐Doménech

Institut Catala d'Oncologia

34H-index
242Paper Count
4.8KCitation Count
Published Papers 56
Publication Date
logo
Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up
errBlood Cancer Journal
IF11.6
err2026-01-28
err0
errOAAI
errEva Domingo-Domènech; Barbara Pro; Tim Illidge; Steven Horwitz; Lorenz Trumper; Swami Iyer; Ranjana Advani; Nancy L. Bartlett; Jacob Haaber Christensen; Won-Seog Kim; Tatyana Feldman; Ilseung Choi; Giuseppe Gritti; David Belada; Andrei Shustov; Arpad Illes; Pier Luigi Zinzani; Andreas Hüttmann; Marek Trneny; Steven Le Gouill; Deepa Jagadeesh; Jonathan W. Friedberg; Meredith Little; Cassie Dong; Michelle Fanale; Keenan Fenton; Kerry J. Savage
errShare
errSave
Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma
errFuture Oncology
IF2.6
err2025-12-10
err0
errOAAI
errNathalie A. Johnson; Pier Luigi Zinzani; Eva Domingo-Domenech; Joshua Brody; Justin Kline; Bijal Dinesh Shah; Amitkumar Nitinkumar Mehta; Herve Ghesquieres; Kerry J. Savage; Paul M. Barr; Armando Santoro; Silvia Ferrari; David Cunningham; Graham P. Collins; Michelle Fanale; Jennifer Krajewski; Alev Akyol; Russell Crowe; Rachael Wen; John Kuruvilla
errShare
errSave
Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial
errThe Lancet
IF97.3
err2025-12-05
err0
PREAI
errLaurie H Sehn; Kai Hübel; Stefano Luminari; Christian W Scholz; Antonio Salar; Shankara Paneesha; Björn Engelbrekt Wahlin; Panayiotis Panayiotidis; Hui-Peng Lee; Ana Jiménez-Ubieto; Juan-Manuel Sancho; Tae Min Kim; Eva Domingo Domenech; Takahiro Kumode; Christina Poh; Catherine Thieblemont; Dries Deeren; Edwin de Wit; Michael Arbushites; Irene Vassallo
errShare
errSave
Asparaginase Hypersensitivity Reactions in NK/T-Cell Lymphomas
errCLINICS AND PRACTICE
IF2.2
err2025-11-17
err0
errOAAI
errVarela Gonzalez-Aller, Javier; Nadal, Pablo; Canizares, Salome; Munoz, Carmen; Valer, Anna; Gonzalez-Barca, Eva; Domingo, Eva; Sureda, Ana; Novelli, Silvana
errShare
errSave
Palindromic rheumatism-like arthritis complicating CAR T-cell therapy
errRHEUMATOLOGY
IF4.4
err2025-11-01
err0
PREAI
errCubells, Monica; Mussetti, Alberto; Oliveira, Ana Carla; Domingo-Domenech, Eva; Narvaez, Javier
errShare
errSave
PRE-TREATMENT SARCOPENIA IS A RISK FACTOR FOR DEVELOPING CLINICALLY RELEVANT CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY
errNEURO-ONCOLOGY
IF13.4
err2025-10-01
err0
errOAAI
errVelasco, R.; Besora, S.; Bellver, M.; Peiro, I; Marco, C.; Andres-Benito, P.; Domingo-Domenech, E.; Santos, C.; Stradella, A.; Laquente, B.; Rodriguez, S.; Arribas, L.; Argyriou, A. A.; Bruna, J.
errShare
errSave
[18F]FDG PET/MRI FOR ASSESSING TREATMENT RESPONSE OF CNS LYMPHOMA: A PROSPECTIVE CASE SERIES
errNEURO-ONCOLOGY
IF13.4
err2025-10-01
err0
errOAAI
errLopez-Pereira, P.; Pons-Escoda, A.; Suarez, M.; Domingo-Domenech, E.; Martinez-Ramos, C.; Majos, C.; Gonzalez-Barca, E.; Villalobos, M.; Vidal, N.; Plans, G.; Bruna, J.; Cortes-Romera, M.; Sureda, A.; Velasco, R.
errShare
errSave
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell Lymphoma
errBlood Advances
IF7.1
err2025-08-21
err0
errOAAI
errSwaminathan Iyer; Neha Mehta-Shah; Ranjana Advani; Nancy L. Bartlett; Jacob H. Christensen; Franck Morschhauser; Eva Domingo-Domenech; Giuseppe Rossi; Won Seog Kim; Onder Alpdogan; Tatyana A. Feldman; Vincent Camus; Giuseppe Gritti; Pier Luigi Zinzani; David Belada; Jiri Mayer; Ilseung Choi; June-Won Cheong; Evelyn Rustia; Keenan Fenton
errShare
errSave
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up
errBlood Cancer Journal
IF11.6
err2025-08-01
err0
errOAAI
errEva Domingo-Domènech; Barbara Pro; Tim Illidge; Steven Horwitz; Lorenz Trumper; Swami Iyer; Ranjana Advani; Nancy L. Bartlett; Jacob Haaber Christensen; Won-Seog Kim; Tatyana Feldman; Ilseung Choi; Giuseppe Gritti; David Belada; Andrei Shustov; Arpad Illes; Pier Luigi Zinzani; Andreas Hüttmann; Marek Trneny; Steven Le Gouill; Deepa Jagadeesh; Jonathan W. Friedberg; Meredith Little; Cassie Dong; Michelle Fanale; Keenan Fenton; Kerry J. Savage
errShare
errSave
A phase Ib/II trial combining brentuximab vedotin with cyclophosphamide, procarbazine, prednisone, etoposide and mitoxantrone (BrEPEM) for older patients with untreated classical Hodgkin lymphoma: A multicentre GELTAMO trial
errBritish Journal of Haematology
IF3.8
err2025-07-25
err0
PREAI
errCecilia Carpio; Fátima de la Cruz-Vicente; Ramon García-Sanz; Izaskun Zeberio; Cristina Barrenetxea; Eva Domingo-Domenech; Mariana Bastos; Araceli Rubio Martinez; Pilar Gómez-Prieto; Antonia Rodriguez; Maria Casanova; Antonia Cladera-Serra; Javier Nuñez Cespedes; Carmen Martínez; Miriam Moreno-Velázquez; Eduardo Garcia-Galea; Pau Abrisqueta; Francesc Bosch
errShare
errSave
Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase 3 Study (inMIND)
errBLOOD
IF23.1
err2024-11-25
err3
PREAI
errSehn, Laurie H.; Luminari, Stefano; Scholz, Christian W.; Huebel, Kai; Salar, Antonio; Paneesha, Shankara; Wahlin, Bjorn E.; Panayiotidis, Panayiotis; Lee, Hui-Peng; Ubieto, Ana Jimenez; Sancho, Juan-Manuel; Kim, Tae Min; Domenech, Eva Domingo; Kumode, Takahiro; Poh, Christina; Thieblemont, Catherine; Deeren, Dries; de Wit, Edwin; Arbushites, Michael; Casadebaig, Marie-Laure; Trneny, Marek
errShare
errSave
Effect of Consolidation with Allogeneic Hematopoietic Cell Transplant Versus No Consolidation in Patients with Non-Hodgkin Lymphomas Treated with Bispecific Antibodies
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errLosi, Giulia; Pena, Marta; Qualls, David A.; Crombie, Jennifer L.; Mariotti, Jacopo; Bramanti, Stefania; Fabbri, Nicole; Serna, Angel; Serroukh, Yasmina I. M.; Balaguer Rosello, Aitana; van der Poel, Marjolein W. M.; Hsu, Ya-Ting; Jimenez Ubieto, Ana; McKinnely, Christopher; Armand, Philippe; Pena, Felipe; Carro, Itziar; Martinez, Carolina; Domingo Domenech, Eva; Lopez Pereira, Patricia; Arevalo Leon, Carolina Esther; Gonzalez Barca, Eva; Sureda Balari, Anna; Mussetti, Alberto
errShare
errSave
Effectiveness and Safety for Re-Treatment with Brentuximab-Vedotin in Patients with Relapsed/Refractory (R/R) CD30+Malignancies: A Retrospective Medical Chart Review Study in Spain. the Believe Study. NCT:04998331
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errGarcia-Sanz, Ramon; Balari, Anna Sureda; Domenech, Eva Domingo; Huelva, Francisco Javier Capote; Gutierrez, Antonio; Izquierdo, Antonia Rodriguez; De Domingo, Marta Grande; Baeza, Lourdes
errShare
errSave
A Multicenter, Open-Label, Phase 3, Randomized Controlled Trial of Duvelisib Versus Investigator's Choice of Gemcitabine or Bendamustine in Patients with Relapsed/Refractory Nodal T Cell Lymphoma with T Follicular Helper Phenotype
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errCwynarski, Kate; Domenech, Eva Domingo; Sidransky, David; Bentur, Ohad S.; Zinzani, Pier Luigi
errShare
errSave
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma
errBLOOD ADVANCES
IF7.1
err2024-08-30
err2
errOAAI
errWitzig, Thomas; Sokol, Lubomir; Kim, Won Seog; Vicente, Fatima de la Cruz; Garcia-Sancho, Alejandro Martin; Advani, Ranjana; Vidal, Jose Maria Roncero; Navarrete, Raquel de Ona; Marin-Niebla, Ana; Izquierdo, Antonia Rodriguez; Terol, Maria Jose; Domingo-Domenech, Eva; Saunders, Andrew; Bendris, Nawal; Mackey, Julie; Leoni, Mollie; Foss, Francine
errShare
errSave
The importance of secondary cancer screening programs in Hodgkin lymphoma survivors
errHAEMATOLOGICA
IF7.9
err2024-07-04
err0
errOAAI
errSalvino, Marco A.; Domingo-Domenech, Eva; Sureda, Anna
errShare
errSave
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
errBLOOD ADVANCES
IF7.1
err2024-05-20
err1
errOAAI
errZinzani, Pier Luigi; Salles, Gilles; Moskowitz, Alison J.; Santoro, Armando; Mehta, Amitkumar; Barr, Paul M.; Mehta-Shah, Neha; Collins, Graham P.; Ansell, Stephen M.; Brody, Joshua D.; Domingo-Domenech, Eva; Johnson, Nathalie A.; Cunningham, David; Ferrari, Silvia; Lisano, Julie; Krajewski, Jennifer; Wen, Rachael; Akyol, Alev; Crowe, Russell; Savage, Kerry J.
errShare
errSave
The Etiology, Antibiotic Therapy and Outcomes of Bacteremic Skin and Soft-Tissue Infections in Onco-Hematological Patients
errANTIBIOTICS-BASEL
IF4.6
err2023-12-13
err1
errOAAI
errCastelli, Valeria; Sastre-Escola, Enric; Puerta-Alcalde, Pedro; Huete-Alava, Leyre; Laporte-Amargos, Julia; Bergas, Alba; Chumbita, Mariana; Marin, Mar; Domingo-Domenech, Eva; Badia-Tejero, Ana Maria; Pons-Oltra, Paula; Garcia-Vidal, Carolina; Carratala, Jordi; Gudiol, Carlota
errShare
errSave
Blood neurofilaments as biomarkers of chemotherapy-induced peripheral neurotoxicity
errJOURNAL OF THE NEUROLOGICAL SCIENCES
IF3.2
err2023-12-01
err0
PREAI
errVelasco, Roser; Marco, Carla; Ferrer, German; Domingo-Domenech, Eva; Stradella, Agostina; Santos, Cristina; Laquente, Berta; Argyriou, Andreas; Bruna, Jordi
errShare
errSave
Beyond remission: secondary primary malignancies in patients with lymphoma after autologous haematopoietic stem-cell transplantation
errLANCET HAEMATOLOGY
IF17.7
err2023-10-01
err0
PREAI
errSureda, Anna; Domingo-Domenech, Eva
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
E
Elı́as Campo
H-index: 173 · Papers: 1.6K
P
Paolo Boffetta
H-index: 167 · Papers: 2.1K
M
Manel Esteller
H-index: 165 · Papers: 1.6K
D
David Cunningham
H-index: 153 · Papers: 2.1K
G
Gilles Salles
H-index: 129 · Papers: 1.7K
View more